APPG Reports

The All-Party Parliamentary Group on Haemophilia and Contaminated Blood has undertaken an inquiry into the current systems of licensing, procurement, commissioning and prescription of treatments for genetic bleeding disorders in the UK. The final report, launched in November 2020 documents the current processes with a focus on how these processes impact on the treatments that patients are offered and can be offered by the NHS. It shows where the processes are working well and where they are not.